Medical Care
Global Infectious Disease In Vitro Diagnostics Market Research Report 2025
- Mar 11, 25
- ID: 76250
- Pages: 84
- Figures: 88
- Views: 16
The global market for Infectious Disease In Vitro Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In Vitro Diagnostics.
The Infectious Disease In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease In Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease In Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
QIAGEN
BD
bioMérieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.
Segment by Type
Instruments
Reagents
Segment by Application
Hospitals & Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease In Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In Vitro Diagnostics.
The Infectious Disease In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease In Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease In Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
QIAGEN
BD
bioMérieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.
Segment by Type
Instruments
Reagents
Segment by Application
Hospitals & Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease In Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Reagents
1.3 Market by Application
1.3.1 Global Infectious Disease In Vitro Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease In Vitro Diagnostics Market Perspective (2020-2031)
2.2 Global Infectious Disease In Vitro Diagnostics Growth Trends by Region
2.2.1 Global Infectious Disease In Vitro Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease In Vitro Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease In Vitro Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease In Vitro Diagnostics Market Dynamics
2.3.1 Infectious Disease In Vitro Diagnostics Industry Trends
2.3.2 Infectious Disease In Vitro Diagnostics Market Drivers
2.3.3 Infectious Disease In Vitro Diagnostics Market Challenges
2.3.4 Infectious Disease In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease In Vitro Diagnostics Players by Revenue
3.1.1 Global Top Infectious Disease In Vitro Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Disease In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease In Vitro Diagnostics Revenue
3.4 Global Infectious Disease In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Disease In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease In Vitro Diagnostics Revenue in 2024
3.5 Global Key Players of Infectious Disease In Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of Infectious Disease In Vitro Diagnostics, Product and Application
3.7 Global Key Players of Infectious Disease In Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Disease In Vitro Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Type (2026-2031)
5 Infectious Disease In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Disease In Vitro Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
6.2 North America Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
6.4 North America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
7.2 Europe Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
7.4 Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
9.2 Latin America Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Introduction
11.1.4 QIAGEN Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.1.5 QIAGEN Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Infectious Disease In Vitro Diagnostics Introduction
11.2.4 BD Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.2.5 BD Recent Development
11.3 bioMérieux SA
11.3.1 bioMérieux SA Company Details
11.3.2 bioMérieux SA Business Overview
11.3.3 bioMérieux SA Infectious Disease In Vitro Diagnostics Introduction
11.3.4 bioMérieux SA Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.3.5 bioMérieux SA Recent Development
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Details
11.4.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Introduction
11.4.4 F. Hoffmann-La Roche, Ltd. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.4.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Details
11.5.2 Hologic, Inc. (Gen-Probe) Business Overview
11.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Introduction
11.5.4 Hologic, Inc. (Gen-Probe) Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.5.5 Hologic, Inc. (Gen-Probe) Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Infectious Disease In Vitro Diagnostics Introduction
11.6.4 Abbott Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.6.5 Abbott Recent Development
11.7 Quidel Corp.
11.7.1 Quidel Corp. Company Details
11.7.2 Quidel Corp. Business Overview
11.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Introduction
11.7.4 Quidel Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.7.5 Quidel Corp. Recent Development
11.8 Siemens Healthineers AG
11.8.1 Siemens Healthineers AG Company Details
11.8.2 Siemens Healthineers AG Business Overview
11.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Introduction
11.8.4 Siemens Healthineers AG Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.8.5 Siemens Healthineers AG Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Details
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Details
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Introduction
11.10.4 Danaher Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.10.5 Danaher Corp. Recent Development
11.11 OraSure Technologies, Inc.
11.11.1 OraSure Technologies, Inc. Company Details
11.11.2 OraSure Technologies, Inc. Business Overview
11.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Introduction
11.11.4 OraSure Technologies, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.11.5 OraSure Technologies, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Reagents
1.3 Market by Application
1.3.1 Global Infectious Disease In Vitro Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease In Vitro Diagnostics Market Perspective (2020-2031)
2.2 Global Infectious Disease In Vitro Diagnostics Growth Trends by Region
2.2.1 Global Infectious Disease In Vitro Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease In Vitro Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease In Vitro Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease In Vitro Diagnostics Market Dynamics
2.3.1 Infectious Disease In Vitro Diagnostics Industry Trends
2.3.2 Infectious Disease In Vitro Diagnostics Market Drivers
2.3.3 Infectious Disease In Vitro Diagnostics Market Challenges
2.3.4 Infectious Disease In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease In Vitro Diagnostics Players by Revenue
3.1.1 Global Top Infectious Disease In Vitro Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Disease In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease In Vitro Diagnostics Revenue
3.4 Global Infectious Disease In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Disease In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease In Vitro Diagnostics Revenue in 2024
3.5 Global Key Players of Infectious Disease In Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of Infectious Disease In Vitro Diagnostics, Product and Application
3.7 Global Key Players of Infectious Disease In Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Disease In Vitro Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Type (2026-2031)
5 Infectious Disease In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Disease In Vitro Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
6.2 North America Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
6.4 North America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
7.2 Europe Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
7.4 Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
9.2 Latin America Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Introduction
11.1.4 QIAGEN Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.1.5 QIAGEN Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Infectious Disease In Vitro Diagnostics Introduction
11.2.4 BD Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.2.5 BD Recent Development
11.3 bioMérieux SA
11.3.1 bioMérieux SA Company Details
11.3.2 bioMérieux SA Business Overview
11.3.3 bioMérieux SA Infectious Disease In Vitro Diagnostics Introduction
11.3.4 bioMérieux SA Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.3.5 bioMérieux SA Recent Development
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Details
11.4.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Introduction
11.4.4 F. Hoffmann-La Roche, Ltd. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.4.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Details
11.5.2 Hologic, Inc. (Gen-Probe) Business Overview
11.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Introduction
11.5.4 Hologic, Inc. (Gen-Probe) Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.5.5 Hologic, Inc. (Gen-Probe) Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Infectious Disease In Vitro Diagnostics Introduction
11.6.4 Abbott Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.6.5 Abbott Recent Development
11.7 Quidel Corp.
11.7.1 Quidel Corp. Company Details
11.7.2 Quidel Corp. Business Overview
11.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Introduction
11.7.4 Quidel Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.7.5 Quidel Corp. Recent Development
11.8 Siemens Healthineers AG
11.8.1 Siemens Healthineers AG Company Details
11.8.2 Siemens Healthineers AG Business Overview
11.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Introduction
11.8.4 Siemens Healthineers AG Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.8.5 Siemens Healthineers AG Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Details
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Details
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Introduction
11.10.4 Danaher Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.10.5 Danaher Corp. Recent Development
11.11 OraSure Technologies, Inc.
11.11.1 OraSure Technologies, Inc. Company Details
11.11.2 OraSure Technologies, Inc. Business Overview
11.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Introduction
11.11.4 OraSure Technologies, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025)
11.11.5 OraSure Technologies, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents
Table 4. Global Infectious Disease In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Infectious Disease In Vitro Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Infectious Disease In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Infectious Disease In Vitro Diagnostics Market Share by Region (2020-2025)
Table 8. Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Infectious Disease In Vitro Diagnostics Market Share by Region (2026-2031)
Table 10. Infectious Disease In Vitro Diagnostics Market Trends
Table 11. Infectious Disease In Vitro Diagnostics Market Drivers
Table 12. Infectious Disease In Vitro Diagnostics Market Challenges
Table 13. Infectious Disease In Vitro Diagnostics Market Restraints
Table 14. Global Infectious Disease In Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Infectious Disease In Vitro Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Infectious Disease In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2024)
Table 17. Ranking of Global Top Infectious Disease In Vitro Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Infectious Disease In Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Infectious Disease In Vitro Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Infectious Disease In Vitro Diagnostics, Product and Application
Table 21. Global Key Players of Infectious Disease In Vitro Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease In Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Infectious Disease In Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. QIAGEN Company Details
Table 47. QIAGEN Business Overview
Table 48. QIAGEN Infectious Disease In Vitro Diagnostics Product
Table 49. QIAGEN Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 50. QIAGEN Recent Development
Table 51. BD Company Details
Table 52. BD Business Overview
Table 53. BD Infectious Disease In Vitro Diagnostics Product
Table 54. BD Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 55. BD Recent Development
Table 56. bioMérieux SA Company Details
Table 57. bioMérieux SA Business Overview
Table 58. bioMérieux SA Infectious Disease In Vitro Diagnostics Product
Table 59. bioMérieux SA Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 60. bioMérieux SA Recent Development
Table 61. F. Hoffmann-La Roche, Ltd. Company Details
Table 62. F. Hoffmann-La Roche, Ltd. Business Overview
Table 63. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product
Table 64. F. Hoffmann-La Roche, Ltd. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 65. F. Hoffmann-La Roche, Ltd. Recent Development
Table 66. Hologic, Inc. (Gen-Probe) Company Details
Table 67. Hologic, Inc. (Gen-Probe) Business Overview
Table 68. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product
Table 69. Hologic, Inc. (Gen-Probe) Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Hologic, Inc. (Gen-Probe) Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Infectious Disease In Vitro Diagnostics Product
Table 74. Abbott Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Quidel Corp. Company Details
Table 77. Quidel Corp. Business Overview
Table 78. Quidel Corp. Infectious Disease In Vitro Diagnostics Product
Table 79. Quidel Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Quidel Corp. Recent Development
Table 81. Siemens Healthineers AG Company Details
Table 82. Siemens Healthineers AG Business Overview
Table 83. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product
Table 84. Siemens Healthineers AG Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Siemens Healthineers AG Recent Development
Table 86. Bio-Rad Laboratories, Inc. Company Details
Table 87. Bio-Rad Laboratories, Inc. Business Overview
Table 88. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product
Table 89. Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Bio-Rad Laboratories, Inc. Recent Development
Table 91. Danaher Corp. Company Details
Table 92. Danaher Corp. Business Overview
Table 93. Danaher Corp. Infectious Disease In Vitro Diagnostics Product
Table 94. Danaher Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Danaher Corp. Recent Development
Table 96. OraSure Technologies, Inc. Company Details
Table 97. OraSure Technologies, Inc. Business Overview
Table 98. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product
Table 99. OraSure Technologies, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 100. OraSure Technologies, Inc. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Infectious Disease In Vitro Diagnostics Picture
Figure 2. Global Infectious Disease In Vitro Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Infectious Disease In Vitro Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Instruments Features
Figure 5. Reagents Features
Figure 6. Global Infectious Disease In Vitro Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Infectious Disease In Vitro Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Infectious Disease In Vitro Diagnostics Report Years Considered
Figure 12. Global Infectious Disease In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Infectious Disease In Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Infectious Disease In Vitro Diagnostics Market Share by Region: 2024 VS 2031
Figure 15. Global Infectious Disease In Vitro Diagnostics Market Share by Players in 2024
Figure 16. Global Top Infectious Disease In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Infectious Disease In Vitro Diagnostics Revenue in 2024
Figure 18. North America Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 20. United States Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 24. Germany Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share by Region (2020-2031)
Figure 32. China Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 40. Mexico Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 44. Turkey Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. QIAGEN Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 48. BD Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 49. bioMérieux SA Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 50. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 51. Hologic, Inc. (Gen-Probe) Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 53. Quidel Corp. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 54. Siemens Healthineers AG Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 55. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 56. Danaher Corp. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 57. OraSure Technologies, Inc. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents
Table 4. Global Infectious Disease In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Infectious Disease In Vitro Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Infectious Disease In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Infectious Disease In Vitro Diagnostics Market Share by Region (2020-2025)
Table 8. Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Infectious Disease In Vitro Diagnostics Market Share by Region (2026-2031)
Table 10. Infectious Disease In Vitro Diagnostics Market Trends
Table 11. Infectious Disease In Vitro Diagnostics Market Drivers
Table 12. Infectious Disease In Vitro Diagnostics Market Challenges
Table 13. Infectious Disease In Vitro Diagnostics Market Restraints
Table 14. Global Infectious Disease In Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Infectious Disease In Vitro Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Infectious Disease In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2024)
Table 17. Ranking of Global Top Infectious Disease In Vitro Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Infectious Disease In Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Infectious Disease In Vitro Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Infectious Disease In Vitro Diagnostics, Product and Application
Table 21. Global Key Players of Infectious Disease In Vitro Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease In Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Infectious Disease In Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Infectious Disease In Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. QIAGEN Company Details
Table 47. QIAGEN Business Overview
Table 48. QIAGEN Infectious Disease In Vitro Diagnostics Product
Table 49. QIAGEN Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 50. QIAGEN Recent Development
Table 51. BD Company Details
Table 52. BD Business Overview
Table 53. BD Infectious Disease In Vitro Diagnostics Product
Table 54. BD Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 55. BD Recent Development
Table 56. bioMérieux SA Company Details
Table 57. bioMérieux SA Business Overview
Table 58. bioMérieux SA Infectious Disease In Vitro Diagnostics Product
Table 59. bioMérieux SA Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 60. bioMérieux SA Recent Development
Table 61. F. Hoffmann-La Roche, Ltd. Company Details
Table 62. F. Hoffmann-La Roche, Ltd. Business Overview
Table 63. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product
Table 64. F. Hoffmann-La Roche, Ltd. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 65. F. Hoffmann-La Roche, Ltd. Recent Development
Table 66. Hologic, Inc. (Gen-Probe) Company Details
Table 67. Hologic, Inc. (Gen-Probe) Business Overview
Table 68. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product
Table 69. Hologic, Inc. (Gen-Probe) Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Hologic, Inc. (Gen-Probe) Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Infectious Disease In Vitro Diagnostics Product
Table 74. Abbott Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Quidel Corp. Company Details
Table 77. Quidel Corp. Business Overview
Table 78. Quidel Corp. Infectious Disease In Vitro Diagnostics Product
Table 79. Quidel Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Quidel Corp. Recent Development
Table 81. Siemens Healthineers AG Company Details
Table 82. Siemens Healthineers AG Business Overview
Table 83. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product
Table 84. Siemens Healthineers AG Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Siemens Healthineers AG Recent Development
Table 86. Bio-Rad Laboratories, Inc. Company Details
Table 87. Bio-Rad Laboratories, Inc. Business Overview
Table 88. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product
Table 89. Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Bio-Rad Laboratories, Inc. Recent Development
Table 91. Danaher Corp. Company Details
Table 92. Danaher Corp. Business Overview
Table 93. Danaher Corp. Infectious Disease In Vitro Diagnostics Product
Table 94. Danaher Corp. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Danaher Corp. Recent Development
Table 96. OraSure Technologies, Inc. Company Details
Table 97. OraSure Technologies, Inc. Business Overview
Table 98. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product
Table 99. OraSure Technologies, Inc. Revenue in Infectious Disease In Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 100. OraSure Technologies, Inc. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Infectious Disease In Vitro Diagnostics Picture
Figure 2. Global Infectious Disease In Vitro Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Infectious Disease In Vitro Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Instruments Features
Figure 5. Reagents Features
Figure 6. Global Infectious Disease In Vitro Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Infectious Disease In Vitro Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Infectious Disease In Vitro Diagnostics Report Years Considered
Figure 12. Global Infectious Disease In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Infectious Disease In Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Infectious Disease In Vitro Diagnostics Market Share by Region: 2024 VS 2031
Figure 15. Global Infectious Disease In Vitro Diagnostics Market Share by Players in 2024
Figure 16. Global Top Infectious Disease In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Infectious Disease In Vitro Diagnostics Revenue in 2024
Figure 18. North America Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 20. United States Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 24. Germany Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share by Region (2020-2031)
Figure 32. China Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 40. Mexico Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share by Country (2020-2031)
Figure 44. Turkey Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Infectious Disease In Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. QIAGEN Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 48. BD Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 49. bioMérieux SA Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 50. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 51. Hologic, Inc. (Gen-Probe) Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 53. Quidel Corp. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 54. Siemens Healthineers AG Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 55. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 56. Danaher Corp. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 57. OraSure Technologies, Inc. Revenue Growth Rate in Infectious Disease In Vitro Diagnostics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Cutting Machines for Diamond Market Research Report 2025
Jul 18, 25
Global RF Shielded Enclosures Market Research Report 2025
Jul 18, 25
Global Padel Court Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232